The market for statins, or cholesterol-lowering drugs, is set to grow by 9% per year until 2006, when it will hit $29 billion. Here's how the competition stacks up:

EST. PEAK GLOBAL SALES COMPANY/DRUG LAUNCH DATE ($ BILLIONS)/DATE

PFIZER/LIPITOR JAN., 1997 12/2009 MERCK/ZOCOR DEC., 1988 8.3/2004 ASTRAZENECA/CRESTOR SEPT.-DEC., 2002 6/2006

Data: Evaluate, Sanford C. Bernstein & Co.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE